Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Beloranib

Pharmacokinetics, Safety, Tolerability and Efficacy of Intravenous Doses of ZGN-433 in Obese Female Volunteers

Zafgen · Phase 1 · Completed · Enrollment 25

NCT01372761

ArmPopulationDoseWeeksEstimandWeight change
Normal SalineObesity or overweightn/rn/rn/rn/r
ZGN-433Obesity or overweightn/rn/rn/rn/r